Caricamento...
Chronic Myeloid Leukemia in a Patient Receiving Tofacitinib: A Case Report and Literature Review
BACKGROUND: Tofacitinib is a new oral Janus kinase inhibitor that has shown promising clinical benefit in various rheumatologic diseases. However, many concerns related to the development of malignancies have been reported with its use. CASE PRESENTATION: A 43-year-old female patient received tofaci...
Salvato in:
| Pubblicato in: | Case Rep Rheumatol |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Hindawi
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6556791/ https://ncbi.nlm.nih.gov/pubmed/31263618 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/2814504 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|